Traws Pharma, Inc. — Form 8-K
Filed July 31, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
On July 29, 2026, Traws Pharma received notice of delisting or failure to satisfy continued listing rules/standards from its exchange. The filing does not specify which exchange, the exact listing standard violated, or remediation timeline. This represents a critical corporate event for a company with ~$9.8M market value.
Why this rating
Delisting is existential threat to small-cap public company; eliminates institutional access, amplifies liquidity crisis, triggers shareholder value destruction disproportionate to firm size
Extracted items
See more from July 31, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.